Neuroscience News

Stanford researchers said they have identified the receptors to which opioid drugs bind to produce tolerance and increased sensitivity to pain, as well as a commercially available drug that limited those side effects in mice.

Stanford neuroscientist Ivan Soltesz, PhD, is a very serious researcher with a focus on the causes of, and treatments for, chronic epileptic seizures in children.

Stanford researchers used a rodent model to discover that shifting the firing pattern of a particular set of brain cells is all it takes to initiate, or to terminate, an absence seizure.

Epilepsy, a pattern of recurrent seizures, affects 1 in 26 people over their lifetime. So-called absence epilepsy (also called petit mal seizures) is most common among children ages 6 to 15 and accounts for about 1 in 20 epilepsy cases.

New research finds that small regions of the brain cycle in and out of sleep, even when awake. The cycles shift toward “awake” when that part of the brain pays attention to a task.

It turns out that tiny little bits of our brains are constantly cycling in and out of sleep, and when those few cells are down, they miss things. What’s more, when neurons are specifically paying attention, they spend less time in the sleepy part of the c

Like a computer’s RAM, working memory serves as a buffer where information, derived from the senses or retrieved from long-term memory, can be temporarily placed so the conscious brain can process it.

The amount of a neurotransmitter called GABA in the dorsolateral prefrontal cortex predicted individuals’ ability to keep several things in mind simultaneously, researchers found.

Tom Stoppard’s latest play, which tackles issues of neuroscience and consciousness – leading to its title, “The Hard Problem” – was followed by a panel discussion with scientists from Stanford and the University of California, Berkeley.

Nothing prevents great researchers from having great personalities.

Stanford neuroscientist Leanne Williams, PhD, has focused her research career on how insights from brain science can help improve care for people with psychiatric conditions.

Big pharmaceutical companies have gradually abandoned their one time obsession with ridding Alzheimer’s patients’ brains of gummy extracellular deposits known as amyloid plaques (they’re composed of a protein called beta-amyloid) that characterize the dis

Engineer Krishna Shenoy, PhD, and graduate student (and then postdoctoral fellow) Paul Nuyujukian, MD, PhD, have updated the algorithms for how they translate the brain signals into typing, which they tested in a series of studies.

Technology for reading signals directly from the brain developed by Stanford Bio-X scientists could provide a way for people with movement disorders to communicate.

Parkinson’s disease, the second-leading neurodegenerative disorder after Alzheimer’s disease, affects one in every 60-70 Americans age 65 or older.

Intracellular defects that lead to cells’ failure to decommission faulty “power packs” known as mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.